Genedrive PLC Company Profile (LON:GDR)

About Genedrive PLC (LON:GDR)

Genedrive PLC logoGenedrive Plc, formerly Epistem Holdings Plc, is a holding company engaged in molecular diagnostics business. The Company operates through segments, including Preclinical Research Services, Pharmacogenomics Services and Diagnostics. Its geographical segments include the United Kingdom, Europe, the United States of America and Asia. Its Preclinical Research Services segment provides pre-clinical testing services. Its Pharmacogenomic Services segment specializes in molecular measures of biological effect. Its Diagnostics segment is commercializing the Genedrive molecular testing platform. Its Preclinical Research Services activities relate to the testing of drugs for drug development companies. The Preclinical Research Services division has developed a range of models across therapeutic pathways, including oncology, gastrointestinal disease, skin care and wound healing. The Pharmacogenomics Service offers multi system transcriptional profiling and laser capture microscopy.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology & Medical Research - NEC
  • Sub-Industry: N/A
  • Symbol: LON:GDR
  • CUSIP: N/A
  • Web:
  • Market Cap: £6.29 million
  • Outstanding Shares: 18,245,000
Average Prices:
  • 52 Week Range: GBX 30 - GBX 80
  • Trailing P/E Ratio:
  • P/E Growth:
Sales & Book Value:
  • Annual Revenue: £5.97 million
  • Price / Sales: 1.05
  • Book Value: GBX 0.39 per share
  • Price / Book: 0.88
  • EBIDTA: ($3,560,000.00)
  • Net Margins: -93.79%
  • Return on Equity: -99.47%
  • Return on Assets: -38.99%
  • Average Volume: 6,569 shs.

Frequently Asked Questions for Genedrive PLC (LON:GDR)

What is Genedrive PLC's stock symbol?

Genedrive PLC trades on the London Stock Exchange (LON) under the ticker symbol "GDR."

When will Genedrive PLC make its next earnings announcement?

Genedrive PLC is scheduled to release their next quarterly earnings announcement on Monday, October, 9th 2017. View Earnings Estimates for Genedrive PLC.

Where is Genedrive PLC's stock going? Where will Genedrive PLC's stock price be in 2017?

1 brokerages have issued twelve-month target prices for Genedrive PLC's stock. Their forecasts range from GBX 200 to GBX 200. On average, they expect Genedrive PLC's stock price to reach GBX 200 in the next year. View Analyst Ratings for Genedrive PLC.

Who are some of Genedrive PLC's key competitors?

Who are Genedrive PLC's key executives?

Genedrive PLC's management team includes the folowing people:

  • David Budd, Chief Executive Officer, Director
  • Matthew Fowler, Chief Financial Officer, Director
  • H. John J. Rylands, Financial Director, Company Secretary, Executive Director
  • Catherine Booth Ph.D., Managing Director - Contract Research Services, Executive Director
  • Allan Brown, Chief Operating Officer - Diagnostics division, Executive Director
  • Ian David Gilham Ph.D., Non-Executive Chairman of the Board
  • Roger Lloyd Ph.D., Non-Executive Director
  • Robert Nolan Ph.D., Non-Executive Director

How do I buy Genedrive PLC stock?

Shares of Genedrive PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Genedrive PLC's stock price today?

One share of Genedrive PLC stock can currently be purchased for approximately GBX 34.50.

MarketBeat Community Rating for Genedrive PLC (LON GDR)
Community Ranking:  3.5 out of 5 (star star star half star)
Outperform Votes:  14 (Vote Outperform)
Underperform Votes:  6 (Vote Underperform)
Total Votes:  20
MarketBeat's community ratings are surveys of what our community members think about Genedrive PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Genedrive PLC (LON:GDR) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: GBX 200

Analysts' Ratings History for Genedrive PLC (LON:GDR)
DateFirmActionRatingPrice TargetDetails
10/11/2016Peel HuntReiterated RatingBuyGBX 200View Rating Details
(Data available from 8/23/2015 forward)


Earnings History for Genedrive PLC (LON:GDR)
Earnings by Quarter for Genedrive PLC (LON:GDR)
Earnings History by Quarter for Genedrive PLC (LON GDR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/9/2017N/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Genedrive PLC (LON:GDR)
Current Year EPS Consensus Estimate: $-34.10 EPS


Dividend History for Genedrive PLC (LON:GDR)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Genedrive PLC (LON:GDR)
No insider trades for this company have been tracked by


Headline Trends for Genedrive PLC (LON:GDR)
Latest Headlines for Genedrive PLC (LON:GDR)
No headlines for this company have been tracked by


Social activity is not available for this stock.


Genedrive PLC (GDR) Chart for Wednesday, August, 23, 2017

This page was last updated on 8/23/2017 by Staff